Abel Hall »

Fate Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2026-03-31 $44k 37k 1.20

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us High Profitab (DUHP)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Small Cap V (DISV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
Acadian Asset Management
Two Sigma Investments
Johnson & Johnson
AQR Capital Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
UBS Group
Goldman Sachs Group
Tang Capital Management

View all funds holding Fate Therapeutics